Viemed Healthcare, Inc. (NASDAQ:VMD) Short Interest Up 48.5% in October

Viemed Healthcare, Inc. (NASDAQ:VMD) saw a significant growth in short interest in October. As of October 15th, there was short interest totalling 305,100 shares, a growth of 48.5% from the September 30th total of 205,500 shares. Approximately 0.9% of the shares of the stock are sold short. Based on an average daily volume of 122,800 shares, the short-interest ratio is presently 2.5 days.

Viemed Healthcare Trading Down 1.0 %

Shares of Viemed Healthcare stock traded down $0.09 during mid-day trading on Monday, hitting $9.15. 72,635 shares of the stock were exchanged, compared to its average volume of 145,011. The company has a 50-day simple moving average of $7.90 and a 200 day simple moving average of $7.44. The company has a current ratio of 1.43, a quick ratio of 1.29 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $355.29 million, a price-to-earnings ratio of 38.50 and a beta of 1.47. Viemed Healthcare has a twelve month low of $5.90 and a twelve month high of $10.44.

Viemed Healthcare (NASDAQ:VMD) last released its earnings results on Wednesday, August 7th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.03). Viemed Healthcare had a net margin of 4.60% and a return on equity of 8.23%. The company had revenue of $54.97 million during the quarter.

Hedge Funds Weigh In On Viemed Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in VMD. Vanguard Group Inc. boosted its stake in shares of Viemed Healthcare by 53.0% in the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after purchasing an additional 617,009 shares during the period. Kent Lake Capital LLC purchased a new stake in shares of Viemed Healthcare during the first quarter worth about $5,557,000. Penbrook Management LLC lifted its stake in shares of Viemed Healthcare by 236.0% in the second quarter. Penbrook Management LLC now owns 231,607 shares of the company’s stock worth $1,517,000 after acquiring an additional 162,670 shares in the last quarter. Apis Capital Advisors LLC grew its stake in Viemed Healthcare by 193.0% during the 2nd quarter. Apis Capital Advisors LLC now owns 234,400 shares of the company’s stock valued at $1,535,000 after purchasing an additional 154,400 shares in the last quarter. Finally, Renaissance Technologies LLC grew its stake in Viemed Healthcare by 50.9% during the 2nd quarter. Renaissance Technologies LLC now owns 438,700 shares of the company’s stock valued at $2,873,000 after purchasing an additional 147,900 shares in the last quarter. Institutional investors and hedge funds own 74.24% of the company’s stock.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.